Results 91 to 100 of about 281,686 (341)

Red-emitting Ba2Si5N8Eu2+ conversion phosphor: A new selection for enhancing the optical performance of the in-cup packaging MCW-LEDs [PDF]

open access: yes, 2018
In this research, the influence of the red-emitting Ba2Si5N8Eu2+ convention phosphor on the optical performance of the 7,000K and 7,700K in-cup packaging multi-chip white LEDs (MCW-LEDs) is investigated.
Minh, Tran Hoang Quang   +3 more
core   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola   +12 more
wiley   +1 more source

Self-polarized RGB device realized by semipolar micro-LEDs and perovskite-in-polymer films for backlight applications

open access: yesOpto-Electronic Advances
In backlighting systems for liquid crystal displays, conventional red, green, and blue (RGB) light sources that lack polarization properties can result in a significant optical loss of up to 50% when passing through a polarizer.
Tingwei Lu   +10 more
doaj   +1 more source

PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon   +13 more
wiley   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Study of TADF Emitters in OLEDs [PDF]

open access: yes, 2015
Delayed fluorescence through thermally activated delayed fluorescence (TADF) has great potential for the creation of inexpensive and highly efficient white lighting applications, with superior colour rendering.
GRAVES, DAVID,RICHARD
core  

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Improvements on Remote Diffuser-Phosphor-Packaged Light-Emitting Diode Systems

open access: yesIEEE Photonics Journal, 2014
By modifying traditional remote phosphor-diffuser-packaged light-emitting diode systems, we have managed to increase the luminous efficacy from 145.7 to 162.3 lm/W.
Hua Xiao   +6 more
doaj   +1 more source

Effect of selected luminescent layers on CCT, CRI, and response times [PDF]

open access: yes, 2019
Phosphors have been used as wavelength converters in illumination for many years. When it is excited with blue light, the frequently used yttrium aluminium garnet doped with cerium (YAG:Ce) phosphor converts a part of blue light to a wideband yellow ...
Jargus, Jan   +4 more
core   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy